当前位置: 首页 >> 检索结果
335. CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.
作者: Sally Hopewell.;An-Wen Chan.;Gary S Collins.;Asbjørn Hróbjartsson.;David Moher.;Kenneth F Schulz.;Ruth Tunn.;Rakesh Aggarwal.;Michael Berkwits.;Jesse A Berlin.;Nita Bhandari.;Nancy J Butcher.;Marion K Campbell.;Runcie C W Chidebe.;Diana Elbourne.;Andrew Farmer.;Dean A Fergusson.;Robert M Golub.;Steven N Goodman.;Tammy C Hoffmann.;John P A Ioannidis.;Brennan C Kahan.;Rachel L Knowles.;Sarah E Lamb.;Steff Lewis.;Elizabeth Loder.;Martin Offringa.;Philippe Ravaud.;Dawn P Richards.;Frank W Rockhold.;David L Schriger.;Nandi L Siegfried.;Sophie Staniszewska.;Rod S Taylor.;Lehana Thabane.;David Torgerson.;Sunita Vohra.;Ian R White.;Isabelle Boutron.
来源: JAMA. 2025年333卷22期1998-2005页
Well-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users.
339. Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes and use of life support over the past 10 years, limiting understanding of practice changes.
|